Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Improving Chronic Illness Care: Translating Evidence Into Action
2001 Standout
Nitric oxide synthases: regulation and function
2011 Standout
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Histological grading and staging of chronic hepatitis
1995 Standout
Liver fibrosis – from bench to bedside
2003 Standout
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis
1991 StandoutNobel
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Hyperuricemia induces endothelial dysfunction
2005 Standout
Raynaud's phenomenon
2001
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
An Algorithm for the Grading of Activity in Chronic Hepatitis C
1996 Standout
Promoting Early Diagnosis and Treatment of Type 2 Diabetes
2000
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Chronic hepatitis B
2007 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Type 1 diabetes
2013 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
1999 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)
2014
Type 2 diabetes mellitus
2015 Standout
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
A systematic review of muscle morphology and function in intermittent claudication
2017 StandoutNobel
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Diabetes classification: grey zones, sound and smoke: Action LADA 1
2008
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
2003
Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study
2001
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
ADMA and oxidative stress
2003
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Steroid Therapy in Severe Viral Hepatitis
1976
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
1994 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
2000
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Role of antimetabolites in immunosuppression and transplantation
1969 StandoutNobel
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease
2000
Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis
1972
Time-Resolved Immunofluorometric Dual-Label Assay for Simultaneous Detection of Autoantibodies to GAD65 and IA-2 in Children with Type 1 Diabetes
2007
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult)
2001
Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
2006
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Rapid Diagnosis of Cytomegaloviral Pneumonia by Tissue Immunofluorescence with a Murine Monoclonal Antibody
1985 StandoutNobel
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b
1993 StandoutNobel
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
The Metabolic Syndrome
2008 Standout
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2011
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
1981 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
2004 Standout
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
2003 Standout
Latent Autoimmune Diabetes in Adults
2009
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Widespread presence of histologically occult cytomegalovirus
1984
Works of I.R. Mackay being referenced
Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes.
1999
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77
2007
A randomised, split‐face comparison of facial hair removal with the alexandrite laser and intense pulsed light system
2007
CHRONIC HEPATITIS: EFFECT OF PROLONGED SUPPRESSIVE TREATMENT AND COMPARISON OF AZATHIOPRINE WITH PREDNISOLONE
1968
Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus.
1995
Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
1993
GENERALIZED CYTOMEGALOVIRUS INFECTION IN A PATIENT WITH LUPOID HEPATITIS
1969